W.P. Carey (W.P. Carey) Risk Assessment

View and export this data going back to 1998. Start your Free Trial

What is W.P. Carey Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of W.P. Carey is: High Risk: Sensitive to economic or industry trends.

Competitive Comparison of W.P. Carey's Risk Assessment

For the REIT - Diversified subindustry, W.P. Carey's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

W.P. Carey's Risk Assessment Distribution in the REITs Industry

For the REITs industry and Real Estate sector, W.P. Carey's Risk Assessment distribution charts can be found below:

* The bar in red indicates where W.P. Carey's Risk Assessment falls into.

W.P. Carey (NYSE:WPC) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

W.P. Carey Risk Assessment Related Terms

Thank you for viewing the detailed overview of W.P. Carey's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

W.P. Carey (W.P. Carey) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » W.P. Carey Inc (NYSE:WPC) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

WPC:Mexico WPY:Germany WPY:Germany

Address

One Manhattan West, 395 9th Avenue, 58th Floor, New York, NY, USA, 10001

Website

https://www.wpcarey.com

W.P. Carey Inc is a real estate investment trust principally involved in the ownership of properties located in the U.S., Western Europe, and Northern Europe. W.P. Carey organizes its operations into Real Estate and Investment Management segments. The vast majority of the company's income is derived from its Real Estate division in the form of lease revenue from long-term agreements with companies. W.P. Carey's real estate portfolio is primarily comprised of single-tenant office, industrial, warehouse, and retail facilities located around the world. most of the company's revenue comes from properties in the USA. The company's Investment Management unit generates revenue from providing real estate advisory and portfolio management services to other REITs.

Executives

Brian H Zander	officer: Chief Accounting Officer	C/O W. P. CAREY INC., ONE MANHATTAN WEST, 395 9TH AVE., 58 FL, NEW YORK NY 10001
Mark A Alexander	director	C/O W. P. CAREY INC., 395 9TH AVENUE, 58TH FLOOR, NEW YORK, NEW YORK NY 10001
Talma Stheeman Mechthild Elisabeth	director	C/O W. P. CAREY INC, ONE MANHATTAN WEST, 395 9TH AVE., 58 FL, NEW YORK NY 10001
Beier Constantin H.	director	C/O W. P. CAREY INC., ONE MANHATTAN WEST 395 9TH AVENUE, 58 FL, NEW YORK, NEW YORK NY 10001
Gino M. Sabatini	officer: Managing Director	C/O W. P. CAREY & CO. LLC, 50 ROCKEFELLER PLAZA, NEW YORK NY 10020
John J Park	officer: President	C/O W. P. CAREY INC., ONE MANHATTAN WEST, 395 9TH AVE. 58TH FL, NEW YORK NY 10001
Jason E. Fox	director, officer: CEO	C/O W. P. CAREY INC., ONE MANHATTAN WEST, 395 9TH AVE., 58 FL, NEW YORK NY 10001
Arjun Mahalingam	officer: Chief Accounting Officer	C/O W. P. CAREY INC., 50 ROCKEFELLER PLAZA, NEW YORK NY 10020
Toniann Sanzone	officer: CFO	C/O W. P. CAREY INC., ONE MANHATTAN WEST, 395 9TH AVE., 58 FL, NEW YORK, NEW YORK NY 10001
Brooks G. Gordon	officer: Managing Director	C/O W. P. CAREY INC., 50 ROCKEFELLER PLAZA, NEW YORK NY 10020
Tonit M Calaway	director	HARLEY-DAVIDSON MOTOR COMPANY, 3700 WEST JUNEAU AVENUE, MILWAUKEE WI 53208
Margaret G Lewis	director	200 COMMERCE STREET, SMITHFIELD VA 23430
Robert J Flanagan	director	C/O SAGENT PHARMACEUTICALS, INC., 1901 NORTH ROSELLE ROAD, SUITE 700, SCHAUMBURG IL 60195
Peter Farrell	director	C/O W. P. CAREY INC., ONE MANHATTAN WEST,395 9TH AVENUE, 58 FL, NEW YORK NY 10001
Van Ommen Nick J.m.	director	C/O W. P. CAREY & CO. LLC, ONE MANHATTAN WEST, 395 9TH AVE. 58 FL, NEW YORK NY 10001